BridgeMD
New treatment option for Oncologic Surgery
Official title Optimal Perioperative Pain Control in Minimally Invasive Abdominal Cancer Surgery
ClinicalTrials.gov ID: NCT06731998
What this study is testing
- What it's testing
- This is a research study to evaluate the effectiveness of 3 different types of routine pain management regimens used during clinically indicated, minimally invasive oncologic (cancer) surgery. This project is considered "Research" and participation is voluntary.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 89
You may be able to join if
- Male and female patients age ≥ 18 - 89
- Patients scheduled for elective (clinically indicated) hepatic, gastric, biliary, pancreatic, gynecologic, colorectal, other GI Minimally invasive...
- Patients who have provided informed consent to participate in the study.
- Patients with an American Society of Anesthesiologists (ASA) physical status classification of I, II, or III.
- Patients undergoing procedures anticipated to last more than 1 hour but less than 8 hours.
You likely can't join if
- Patients age less than 18 or ≥ 90
- Pre-existing hepatic dysfunction, cirrhosis
- Patients with an ASA classification of IV or higher.
- Patients with chronic pain disorders or on long-term opioid or analgesic therapy.
- Patients with known contraindications to the study drugs or procedures (e.g., allergy to LA or contraindications to LapTAP).
- Patients with cognitive impairments or psychiatric conditions that could interfere with pain assessment or understanding of informed consent.
See the full eligibility criteria
- Male and female patients age ≥ 18 - 89
- Patients scheduled for elective (clinically indicated) hepatic, gastric, biliary, pancreatic, gynecologic, colorectal, other GI Minimally invasive oncologic surgery.
- Patients who have provided informed consent to participate in the study.
- Patients with an American Society of Anesthesiologists (ASA) physical status classification of I, II, or III.
- Patients undergoing procedures anticipated to last more than 1 hour but less than 8 hours.
- Patients able to understand and self-report pain using the designated pain Visual Analog Scale
- Patients age less than 18 or ≥ 90
- Pre-existing hepatic dysfunction, cirrhosis
- Patients with an ASA classification of IV or higher.
- Patients with chronic pain disorders or on long-term opioid or analgesic therapy.
- Patients with known contraindications to the study drugs or procedures (e.g., allergy to LA or contraindications to LapTAP).
- Patients with cognitive impairments or psychiatric conditions that could interfere with pain assessment or understanding of informed consent.
- Patients unable to understand the language in which consent and study-related information are provided (The study and the study-related information will be in the English Language)..
- Patients who have undergone major surgery within the last 6 months.
- Female patients who are pregnant.
- Patients currently enrolled in another clinical trial that might interfere with the outcome measures of this study.
The study team makes the final eligibility decision.
Where it's taking place
- Pittsburgh, Pennsylvania, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 89 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Pittsburgh, Pennsylvania, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.